Related Experiment Video
Updated: Jun 16, 2025
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Mathematical modeling and mechanisms of HIV latency for personalized anti latency therapies
Gianmarco Rasi1,2, Elena Emili3, Jessica M Conway4
1Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, 00165, Rome, Italy.
Abstract:
Combination antiretroviral therapy controls human immunodeficiency virus-1 (HIV) but cannot eradicate latent proviruses in immune cells, which reactivate upon treatment interruption. Anti-latency therapies like "shock-and-kill" are being developed but are yet to succeed due to the complexity of latency mechanisms. This review discusses recent advances in understanding HIV latency via mathematical modeling, covering key regulatory factors and models to predict latency reversal, highlighting gaps to guide future therapeutic approaches.
Insights
Mathematical modeling advances our understanding of human immunodeficiency virus-1 (HIV) latency, crucial for developing effective anti-latency therapies to combat persistent viral reservoirs. This review highlights key factors and predictive models to guide future shock-and-kill strategies.
Area of Science:
- Virology
- Immunology
- Computational Biology
Background:
- Combination antiretroviral therapy (cART) effectively controls human immunodeficiency virus-1 (HIV) replication.
- Latent HIV proviruses persist in immune cells, reactivating upon cART cessation, posing a significant barrier to eradication.
- Current anti-latency strategies, such as "shock-and-kill", face challenges due to the intricate mechanisms of HIV latency.
Purpose of the Study:
- To review recent advancements in understanding HIV latency mechanisms.
- To explore the application of mathematical modeling in deciphering HIV latency.
- To identify key regulatory factors and predictive models for latency reversal.
Main Methods:
- Literature review of recent studies on HIV latency.
- Analysis of mathematical models used to simulate and predict HIV latency dynamics.
- Discussion of regulatory factors influencing proviral latency and reactivation.
Main Results:
- Mathematical modeling provides critical insights into the complex regulatory networks governing HIV latency.
- Identified key factors and pathways that can be targeted for latency reversal.
- Highlighted the predictive power of computational models for assessing therapeutic interventions.
Conclusions:
- A deeper understanding of HIV latency mechanisms, aided by mathematical modeling, is essential for developing curative strategies.
- Future research should focus on refining predictive models and exploring novel therapeutic targets to overcome latency.
- Bridging the gap between theoretical models and experimental validation is crucial for advancing anti-latency therapies.
